Literature DB >> 12572876

Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism.

Kyoko Miyasaka1, Yutaka Takata, Akihiro Funakoshi.   

Abstract

BACKGROUND: The etiology of gallstone formation is multifactorial, and genetic factors are involved. The genetic variations of cholecystokinin A receptor (CCK-AR) in patients having gallstones and the molecular mechanisms of this polymorhpism were examined. The involvement of CCK-AR in gallstone formation was confirmed using CCK-AR gene knockout mice.
METHODS: CCK-AR gene expression was determined by Northern transfer analysis in gallbladders with or without gallstones. Genetic variations were determined by Southern blot and by direct sequencing. Molecular mechanisms in terms of the transcriptional activity and methylation status were examined. Finally, we investigated whether gallstone formation was enhanced in CCK-AR gene knockout mice.
RESULTS: The gene expression of CCK-AR was significantly decreased in gallbladders with gallstones compared to those without gallstones. No genetic variations were detected in the coding region, but two sequence variations were detected in the promoter region in gallstone patients. However, no significant differences were found for the promoter activities of polymorphic promoter constructs. In contrast, less methylation in the promoter region was related to substantial expression of the CCK-AR gene. Gallstone formation was enhanced in CCK-AR gene knockout mice. The homozygote (GG/TT) polymorphism of the CCK-AR gene showed a significantly higher percentage of body fat.
CONCLUSIONS: Deteriorating gallbladder contractions, possibly induced by alterations in the CCK-AR gene, as well as CCK-AR gene polymorphism, promoted gallstone formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12572876     DOI: 10.1007/BF03326426

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  24 in total

Review 1.  [Cholecystokinin (CCK) type-A receptor gene abnormality and life style related diseases].

Authors:  A Funakoshi; K Miyasaka
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2000-03

2.  Mechanisms of gallbladder hypomotility in pregnant guinea pigs.

Authors:  Z L Xiao; Q Chen; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

3.  Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  H Inoue; C A Iannotti; C M Welling; R Veile; H Donis-Keller; M A Permutt
Journal:  Genomics       Date:  1997-06-01       Impact factor: 5.736

4.  Highlights of the meeting on prevention of gallstones.

Authors:  S M Grundy; S C Kalser
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

5.  Complications of obesity.

Authors:  G A Bray
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

6.  Importance of CCK-A receptor for gallbladder contraction and pancreatic secretion: a study in CCK-A receptor knockout mice.

Authors:  S Suzuki; S Takiguchi; N Sato; S Kanai; T Kawanami; Y Yoshida; K Miyasaka; Y Takata; A Funakoshi; T Noda
Journal:  Jpn J Physiol       Date:  2001-10

7.  Mechanism of cholecystokinin-A- receptor antagonist on human pancreatic exocrine secretion. Localization of CCK-A receptor in the human duodenum.

Authors:  A Funakoshi; Y Fukamizu; K Miyasaka
Journal:  Digestion       Date:  1999       Impact factor: 3.216

8.  Signal transduction pathways mediating CCK-induced gallbladder muscle contraction.

Authors:  P Yu; Q Chen; Z Xiao; K Harnett; P Biancani; J Behar
Journal:  Am J Physiol       Date:  1998-08

9.  Methylation profiling of CpG islands in human breast cancer cells.

Authors:  T H Huang; M R Perry; D E Laux
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

Review 10.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11
View more
  14 in total

Review 1.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

2.  Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism.

Authors:  Wei Huang; Rishipal R Bansode; Yan Xie; Leslie Rowland; Madhu Mehta; Nicholas O Davidson; Kamal D Mehta
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

3.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

Review 4.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

5.  Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China.

Authors:  Hong-Li Xu; Ann W Hsing; Emily Vogtmann; Lisa W Chu; Jia-Rong Cheng; Jing Gao; Yu-Ting Tan; Bing-Sheng Wang; Ming-Chang Shen; Yu-Tang Gao
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

6.  Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls.

Authors:  Monica Acalovschi; Simona Tirziu; Erica Chiorean; Marcin Krawczyk; Frank Grünhage; Frank Lammert
Journal:  Lipids       Date:  2009-04-30       Impact factor: 1.880

Review 7.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice.

Authors:  Guo-Qiang Xu; Cheng-Fu Xu; Hong-Tan Chen; Shan Liu; Xiao-Dong Teng; Gen-Yun Xu; Chao-Hui Yu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  Lack of cholecystokinin-A receptor enhanced gallstone formation: a study in CCK-A receptor gene knockout mice.

Authors:  Norikazu Sato; Kyoko Miyasaka; Shinji Suzuki; Setsuko Kanai; Minoru Ohta; Takako Kawanami; Yuki Yoshida; Soichi Takiguchi; Tetsuo Noda; Yutaka Takata; Akihiro Funakoshi
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

10.  Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis.

Authors:  Yanzhao Xu; Na Wang; Rongfeng Liu; Huilai Lv; Zhenhua Li; Fan Zhang; Chunyue Gai; Ziqiang Tian
Journal:  Onco Targets Ther       Date:  2021-05-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.